Joanne Wiseman

Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDS and Cox 2 inhibitors

Charles J. Grossman, Joanne Wiseman, Fiona S. Lucas et al. · Inflammation Research · 1995 · 125 citations

Inflammation, Thrombosis, Thrombopoiesis +12

Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors

J. Hamblin, Tony D. Angell, Stuart P. Ballantine et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 71 citations · Full text

Combinatorial Chemistry, Novel Structural Class, Biochemistry +6

GSK256066, an Exceptionally High-Affinity and Selective Inhibitor of Phosphodiesterase 4 Suitable for Administration by Inhalation: In Vitro, Kinetic, and In Vivo Characterization

Cathy Tralau-Stewart, Richard A. Williamson, Anthony T. Nials et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 69 citations

The Cyclooxygenase-2 Inhibitor GW406381X [2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] Is Effective in Animal Models of Neuropathic Pain and Central Sensitization

Sharon Bingham, Paul Beswick, C. Bountra et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 63 citations

Pre treatment with MK-801, a non-competitive NMDA antagonist, prevents development of mechanical hyperalgesia in a rat model of chronic neuropathy, but not in a model of chronic inflammation

Gary D. Smith, Joanne Wiseman, Samantha Harrison et al. · Neuroscience Letters · 1994 · 62 citations

Inflammation, Pain Syndrome, Pre Treatment +12